Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

September 2021 Issue of The Medicine Maker

In this issue, our cover features looks at the mRNA field – asking what lies ahead for mRNA post-pandemic, featuring contributions from CureVac, Sartorius, and more. We also speak with the Drugs for Neglected Diseases initiative to learn about a partnership that brought a new hep C treatment to Malaysia. In In My View, we cover advanced therapies, rapid-dissolve tablet technologies, and the pharma supply chain. We also sit down with Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Discovery & Development Drug Discovery

A Breath of Fresh Air

| Maryam Mahdi

Repurposing drugs could accelerate the development of a new cystic fibrosis drug.

Discovery & Development Drug Discovery

Archived Antivirals

| Angus Stewart

Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.

Business & Regulation Standards & Regulation

Of Medicine and Machine Learning

| Angus Stewart, Stephanie Sutton

AI is expanding into medicine. Are the world’s regulators ready?

Business & Regulation Standards & Regulation

The Winding Road to the Frontline for Advanced Therapies

| Angi Robinson

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.

Manufacture Formulation

A Nice Cup of RDT

| Aditya Kumar

Has pharma fully acknowledged the power of rapid-dissolve tablet technologies?

Manufacture Supply Chain

Moving Beyond Clinical Manufacturing

| Joe Garrity

How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.

Discovery & Development Clinical Trials

Malaysia in the Middle: Tackling Hep C in an Unfair World

| Angus Stewart

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

Manufacture Drug Discovery

Bringing Certainty to CAR T-Cell Discovery

| Jim Ross

How can we maximize the potential and production of potentially life-saving therapies?

Manufacture Technology and Equipment

Now You See It

| Andrea Sardella

What are the challenges and best practices in quality control for difficult-to-inspect products?

Other issues of 2021